La cadena de opciones muestra datos clave de las opciones de acciones de Quince Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Quince Therapeutics..

Quince Therapeutics (NASDAQ:QNCX) Bolsa, Cadena de Opciones

QUINCE THERAPEUTICS INC

Quince Therapeutics

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Quince Therapeutics Inc

WIIM

STRO

MicroSutro Biopharma shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight.

MICROALGO INC.
NOTICE OF EXTRAORDINARY GENERAL MEETING OF MEMBERS
To Be Held on July&nbsp;2, 2025
&nbsp;
To the Shareholders of MicroAlgo Inc:
&nbsp;
NOTICE IS HEREBY GIVEN, that you are cordially invited to attend an extraordinary general meeting (the "Extraordinary Meeting") of shareholders of MicroAlgo Inc., a Cayman Islands exempted company with limited liability (the "Company," "we," "us" or "our"). The Extraordinary Meeting is to be held at Company headquarters located at Unit 507, Building C, Taoyuan Street, Long Jing High and New Technology Jingu Pioneer Park, Nanshan District, Shenzhen, People's Republic of China, at 9:00 a.m., Beijing time, on Wednesday, July&nbsp;2, 2025, and at any adjournment or adjournments thereof, at which the following will be proposed:
&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>1.</td>
<td>
As an ordinary resolution, to undertake a 30-for-1 share consolidation of the issued and unissued shares of the Company, such that (i) every thirty (30) Class A Ordinary Shares of a par value of US$0.2 each be consolidated into one (1) Class A Ordinary Share with a par value of US$6.00 each, and (ii) every thirty (30) Class B Ordinary Shares of a par value of US$0.2 each be consolidated into one (1) Class B Ordinary Share with a par value of US$6.00 each (the "Share Consolidation"), with such Share Consolidation to be effective immediately following the approval of the shareholders of the Company.
Upon the Share Consolidation becoming effective, the authorized share capital of the Company shall be changed:
FROM US$200,000,000 divided into 1,000,000,000 shares comprising of (i) 800,000,000 Class A Ordinary Shares of a par value of US$0.2 each, and (ii) 200,000,000 Class B Ordinary Shares of a par value of US$0.2 each,
TO US$200,000,000 divided into 33,333,333.33 shares comprising of (i) 26,666,666.67 Class A Ordinary Shares of a par value of US$6.00 each, and (ii) 6,666,666.67 Class B Ordinary Shares of a par value of US$6.00 each (together, the "Consolidated Shares"),
&nbsp;
and that no fractional shares shall be issued in connection with the Share Consolidation. In accordance with the currently effective memorandum and articles of association of the Company (the "Memorandum and Articles"), the Company's transfer agent shall be authorized and instructed to aggregate all fractional shares and sell them as soon as practicable after the effective time of the Share Consolidation at the then-prevailing prices on the open market, on behalf of those shareholders who would otherwise be entitled to receive a fraction of a Consolidated Share as a result of the Share Consolidation.
</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>2.</td>
<td>
As an ordinary resolution, immediately following the effectiveness of the Share Consolidation, the authorized share capital of the Company shall be increased (the "Increase of Capital"):
FROM: US$200,000,000 divided into 33,333,333.33 shares comprising of (i) 26,666,666.67 Class A Ordinary Shares of a par value of US$6.00 each, and (ii) 6,666,666.67 Class B Ordinary Shares of a par value of US$6.00 each,
TO: US$6,000,000,000 divided into 1,000,000,000 shares comprising of (i) 800,000,000 Class A Ordinary Shares of a par value of US$6.00 each, and (ii) 200,000,000 Class B Ordinary Shares of a par value of US$6.00 each (together, the "Adjusted Shares"),
&nbsp;
such increase to be effected by the creation of 773,333,333.33 additional Class A Ordinary Shares and 193,333,333.33 additional Class B Ordinary Shares.
</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;
&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>3.</td>
<td>
As a special resolution, (i) immediately subsequent to the implementation of the Share Consolidation and the Increase of Capital and (ii) subject to and conditional upon, amongst other things, approval from the Grand Court of the Cayman Islands (the "Court") of the Capital Reduction (as defined below); (iii) registration by the Registrar of Companies of Cayman Islands of the order of the Court confirming the Capital Reduction and the minute approved by the Court containing the particulars required under the Companies Act (Revised) of the Cayman Islands (the "Companies Act") in respect of the Capital Reduction and compliance with any conditions the Court may impose; (iv) compliance with the relevant procedures and requirements under the applicable laws of Cayman Islands to effect the Capital Reduction and (v) obtaining of all necessary approvals from the regulatory authorities or otherwise as may be required in respect of the Capital Reduction and Reorganization (as defined below), with effect from the date on which these conditions are fulfill:
&nbsp;
the par value of each of the then issued Adjusted Shares should be reduced from US$6.00 to US$0.0000001 by cancelling the paid-up capital of the Company to the extent of US$5.9999999 on each of the then issued Adjusted Shares (the "Capital Reduction");
&nbsp;
the credit arising from the Capital Reduction be transferred to a distributable reserve account of the Company which may be utilized by Company as the board of directors of the Company may deem fit and permitted under the Companies Act, the Memorandum and Articles and all relevant applicable laws, including, without limitation, eliminating or setting off any accumulated losses of the Company (if any) from time to time;
&nbsp;
immediately after the Capital Reduction, each of the authorised but unissued Adjusted Shares of a par value of US$6.00 each be sub-divided into 60,000,000 shares of a par value of US$0.0000001 each (the "Share Sub-Division");
immediately following the Capital Reduction and the Share Sub-Division, the authorised share capital of the Company be changed;
FROM: US$6,000,000,000 divided into 1,000,000,000 shares comprising of (i) 800,000,000 Class A Ordinary Shares of a par value of US$6.00 each, and (ii) 200,000,000 Class B Ordinary Shares of a par value of US$6.00 each,
TO: US$100 divided into 1,000,000,000 shares comprising of (i) 800,000,000 Class A Ordinary Shares of a par value of US$0.0000001 each (the "New Class A Ordinary Shares"), and (ii) 200,000,000 Class B Ordinary Shares of a par value of US$0.0000001 each (the "New Class B Ordinary Shares"),
by cancelling the excess authorized but unissued shares in the authorized share capital of the Company (the steps above shall be collectively referred to as the "Capital Reduction and Reorganisation");
each of the New Class A Ordinary Shares and the New Class B Ordinary Shares arising from the Capital Reduction and Reorganization shall rank pari passu in all respects with each other respectively and shall have the rights and privileges and be subject to the restrictions as contained in the Memorandum and Articles; and
any one or more of the directors of the Company be and is/are hereby authorized to do all such acts and things and execute all such documents, which are in connection with and/or ancillary to the Capital Reduction and Reorganization and any of the foregoing steps and of administrative nature, on behalf of the Company, including under seal where applicable, as he/she/they consider necessary, desirable or expedient to give effect to the foregoing arrangements for the Capital Reduction and Reorganization and (where applicable) to aggregate all fractional New Class A Ordinary Shares and New Class B Ordinary Shares and sell them for the benefits of the Company.
</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;
&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>
As a special resolution, with effect from the effective date of the Capital Reduction and Reorganization, the following sentence of clause 8 of the existing memorandum of association of the Company,
"The share capital of the Company is US$200,000,000 divided into 1,000,000,000 shares comprising of (i) 800,000,000 Class A Ordinary Shares of a par value of US$0.2 each, and (ii) 200,000,000 Class B Ordinary Shares of a par value of US$0.2 each.",
</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>
should be deleted and replaced by the following,
"The share capital of the Company is US$100 divided into 1,000,000,000 shares comprising of (i) 800,000,000 Class A Ordinary Shares of a par value of US$0.0000001 each, and (ii) 200,000,000 Class B Ordinary Shares of a par value of US$0.0000001 each."
</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;
The foregoing items of business are more fully described in the proxy statement accompanying this Notice. We are not aware of any other business to come before the Extraordinary Meeting.
&nbsp;
Only shareholders of record at the close of business on June&nbsp;9, 2025 are entitled to notice and to vote at the Extraordinary Meeting and any adjournment or postponement thereof.
&nbsp;
It is important that your shares are represented at the Extraordinary Meeting. We urge you to review the attached Proxy Statement and, whether or not you plan to attend the Extraordinary Meeting in person, please vote your shares promptly by casting your vote via the Internet, or, if you prefer to mail your proxy or voter instructions, please complete, sign, date, and return your proxy or vote instruction form in the pre-addressed envelope provided, which requires no additional postage if mailed in the United States. You may revoke your vote by submitting a subsequent vote over the Internet or by mail before the Extraordinary Meeting, or by voting in person at the Extraordinary Meeting.

News

Stock Split

MLGO

Reported June 13, 2025: MicroAlgo Proposes 30-For-1 Reverse Stock Split; Extraordinary Meeting To Be Held on July 2, 2025

<a href="https://abcnews.go.com/Politics/netanyahu-tells-abc-ruling-taking-irans-supreme-leader/story?id=122868515">https://abcnews.go.com/Politics/netanyahu-tells-abc-ruling-taking-irans-supreme-leader/story?id=122868515</a>

General

iShares MSCI Israel Capped Investable Market Index Fund

'Netanyahu tells ABC he's not ruling out taking out Iran's Supreme Leader Ayatollah Khamenei'- ABC News

Evercore ISI Group analyst Mark Mahaney initiates coverage on MNTN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNTN#NYSE">MNTN</a>) with a Outperform rating and announces Price Target of $27.

Price Target

Initiation

Analyst Ratings

MNTN

Evercore ISI Group Initiates Coverage On MNTN with Outperform Rating, Announces Price Target of $27

Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) has outperformed the market over the past 15 years by 10.13% on an annualized basis producing an average annual return of 22.17%. Currently, Apple has a market capitalization of $2.96 trillion. 
Buying $1000 In AAPL: If an investor had bought $1000 of AAPL stock 15 years ago, it would be worth $20,426.10 today based on a price of $197.09 for AAPL at the time of writing.
<h3>Apple's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750092312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

AAPL

Here's How Much You Would Have Made Owning Apple Stock In The Last 15 Years

Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) and Universal, the powerhouse studios behind Star Wars, Frozen, and Kung Fu Panda, have filed a major copyright lawsuit involving an <a href="https://www.benzinga.com/news/topics/25/06/45847032/ibm-acquires-ai-startup-seek-and-launches-500m-backed-watsonx-ai-labs-in-nyc-to-tackle-data-innovation-with-agentic-intelligence">AI startup</a>, described by <a href="https://www.entrepreneur.com/business-news/disney-universal-sue-ai-startup-midjourney-plagiarism/493100">Entrepreneur</a> as a potential first for <a href="https://www.benzinga.com/25/05/45651756/streaming-wars-heat-up-how-moonvalleys-123m-ai-bet-could-shape-hollywoods-future">Hollywood</a>. The case targets Midjourney, a text-to-image generator that allegedly enabled users to produce visuals featuring copyrighted characters owned by the studios.
Filed in the U.S. District Court in Los Angeles, the 110-page complaint accuses Midjourney of building a commercial enterprise off protected intellectual property. According to the lawsuit, the studios had issued cease-and-desist letters to Midjourney's counsel, demanding the unauthorized content be stopped.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
&#8220;Midjourney, which has attracted millions of subscribers and made $300 million last year alone, is focused on its own bottom line and ignored Plaintiffs' demands,&#8221; the filing reads. When those warnings were ignored, Disney and Universal moved forward with legal action. The lawsuit says that Midjourney&#8217;s paid plans reportedly range from $10 to $120 per month, contributing to its explosive financial growth since launching.
<h2 class="wp-block-heading">Midjourney&#8217;s Fast Growth Draws Major Legal Firepower</h2>
Founded in 2021, Midjourney has grown rapidly by offering AI-generated images within seconds, fueled entirely by user prompts. With just 11 full-time employees, the company <a href="https://www.midjourney.com/home">describes</a> itself as a small, self-funded operation. The lawsuit alleges its rapid expansion has come at the expense of long-established copyrights, turning beloved characters into AI fodder without authorization.
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
The lawsuit highlights a roster of well-known characters allegedly reproduced by Midjourney's platform. Disney's complaint cites the unauthorized use of Darth Vader from Star Wars, Elsa from Frozen, Lightning McQueen from Cars, and Homer Simpson from The Simpsons. Universal's claims include the depiction of Minions from Despicable Me, Po from Kung Fu Panda, Shrek, as well as Hiccup and Toothless from How to Train Your Dragon.
According to the filing, only the studios maintain legal rights to commercialize these characters and develop content or merchandise around them. One line in the complaint describes Midjourney as a "bottomless pit of plagiarism," accusing the startup of undermining the basic framework of U.S. copyright law. The studios are seeking a jury trial to establish boundaries around what generative AI platforms can legally create.
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>
<h2 class="wp-block-heading">Broader Battle Looms For AI And Copyright Control</h2>
In the filing, Disney and Universal frame the lawsuit as more than a defense of individual characters, describing Midjourney's business model as a direct threat to the creative economy and the broader U.S. film industry.
Calling the infringement "systematic, ongoing, and willful," the plaintiffs argue the damage is both substantial and irreparable, not just to their own properties but to the incentive system that fuels the $260 billion American motion picture economy.
The lawsuit arrives during a critical moment for AI litigation. Just one week prior, Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) filed its own suit against Anthropic, alleging unauthorized use of its forum content for AI training purposes,<a href="https://www.wsj.com/tech/ai/reddit-lawsuit-anthropic-ai-3b9624dd"> The Wall Street Journal</a> reports. Getty Images (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) is also<a href="https://copyrightalliance.org/wp-content/uploads/2023/02/Getty-Images-v.-Stability-AI-Complaint.pdf"> pursuing</a> a multimillion dollar case against Stability AI for allegedly scraping over 12 million copyrighted visuals from its platform.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

GETY

RDDT

Hollywood Showdown Begins: Disney And Universal Sue $300M AI Startup Midjourney For 'Bottomless Pit Of Plagiarism' In Blockbuster Case

The Company has been made aware of a recent increase in commentary, speculation, and information concerning the Company being circulated through various online and social media platforms. The Company cautions investors that it does not endorse or verify information posted on these unofficial channels, which may contain incomplete, inaccurate, or misleading statements. Investors should not rely on any of these sources for their investment decisions. The Company is committed to providing transparent and accurate information to the market and urges all investors to rely exclusively on information that is filed or furnished by the Company with the U.S. Securities and Exchange Commission (SEC) or is made available on its official investor relations website at <a href="http://www.microalgor.com" title="www.microalgor.com">www.microalgor.com</a>

MicroAlgo Cautions Investors Against Relying On Unofficial Online Commentary And Reaffirms Commitment To Providing Accurate Information Via SEC Filings And Official Channels

BofA Securities analyst Jessica Reif Ehrlich <a href="https://www.benzinga.com/quote/WBD/analyst-ratings" target="_blank" rel="noreferrer noopener">maintained a Buy</a> on Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) with a price target of $14 on Monday.
Ehrlich noted that Warner Bros has a compelling assortment of assets. The company&#8217;s upcoming catalysts included easing Studio comparisons, potential recovery in advertising, continued growth in DTC and execution of further strategic options to drive shareholder value.
Also Read: <a href="https://www.benzinga.com/general/entertainment/25/05/45327859/warner-bros-streaming-growth-cost-cuts-highlighted-analysts-stay-cautious" target="_blank" rel="noreferrer noopener">Warner Bros&#8217; Streaming Growth, Cost Cuts Highlighted, Analysts Stay Cautious</a>
On June 9, Warner Bros announced plans to separate the company into <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45845734/warner-bros-discoverys-long-predicted-split-is-now-official">two publicly traded entities in a tax-free transaction</a>. The analyst reiterated having long viewed exploring strategic options, such as the announced spin, as the best way to unlock the significant unrecognized value of the company.
While several different permutations exist around the specific corporate structures of both entities, Ehrlich explored numerous hypothetical transaction scenarios that indicate the potential for significant equity value creation relative to current levels.
The analyst had long noted that Warner Bros. Studio is the crown jewel of all studios in media. The value inherent in the IP and libraries of this asset has been overshadowed by substantial leverage and secular challenges within the linear business, the analyst said. With the streaming and studio assets soon to be unburdened by the constraints of an onerous debt load, she noted the company would have greater flexibility to invigorate the studio. It could make this asset a more attractive target for companies wishing to acquire more scale.
Ehrlich noted that investor sentiment related to the linear business is quite negative, given the existing secular challenges within the ecosystem. However, the analyst pointed out that equity value creation opportunities remain underappreciated at current valuations and under the appropriate capital structure and management team.
She noted several options, including managing the business for cash, consolidating with other similar linear assets, asset sales, and private equity investments, as potential vehicles to create shareholder value.
Ehrlich projected 2025 sales of $38.2 billion.
WBD&nbsp;Price Action: WBD stock is up 4.94% at $10.53 at&nbsp;publication on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/45731052/warner-bros-debt-downgrade-is-an-ironically-positive-event-analyst" target="_blank" rel="noreferrer noopener">Warner Bros&#8217; Debt Downgrade Is An &#8216;Ironically Positive&#8217; Event: Analyst</a></li>
</ul>
Photo: Shutterstock

Entertainment

Reiteration

Media

Warner Bros Spin-Off Could Unlock Hidden Value As Ads Rebound, Streaming Gains Momentum: Analyst

<a href="https://www.benzinga.com/startups/24/12/42618228/mark-cuban-admits-ive-gotten-beat-after-losing-20-million-on-shark-tank-startups">Mark Cuban</a> isn't usually moved by emotion on "Shark Tank." But when Kaitlin Mogentale stood in front of the Sharks in 2022 and revealed her sustainable chip company was hanging by a financial thread — Cuban didn't flinch. He invested $500,000.
Mogentale's pitch started with a problem: 54 million tons of food are wasted in the U.S. each year. Her solution? Pulp Pantry — a snack company that turns leftover fruit and vegetable pulp into fiber-rich, potato-free chips.
"We take the thousands of pounds of organic produce that would otherwise go unloved every single week," she <a href="https://youtu.be/-RuHX7YSmgA?si=wmZbFzXwhzZjWidn">explained on the episode</a>, "and upcycle them into a line of real veggie chips… not corn, not potato starch."
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
The chips were a hit with the Sharks, but not everyone bit. Mogentale asked for $500,000 in exchange for 10% equity — a $5 million valuation. Barbara Corcoran bowed out, calling the snack space too competitive. Emma Grede passed too, saying the valuation "was a little nuts." Kevin O'Leary offered $500,000 but wanted 25%. Lori Greiner floated a $500,000 loan at 6% interest over three years — plus the same 10% equity.
Then it was Cuban's turn.
Before making his offer, Cuban asked a simple question: "What's the lowest you've ever been at?"
Mogentale hesitated. "I don't know if I should tell you."
"We've all been negative," Cuban said, encouraging her to open up.
She admitted her balance had dropped to "like a thousand dollars."
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
Cuban didn't just relate — he respected the grind. "You have to ask yourself where can you get to… because that's really where the value comes from."
Long before the billions, Cuban was eating mustard sandwiches, sleeping on the floor of a Dallas apartment with five roommates, and driving a <a href="https://www.benzinga.com/personal-finance/24/08/40442345/mark-cuban-says-he-drove-cars-that-cost-200-with-holes-in-the-floorboard-and-lived-off-mac-and-c">$200 car with holes in the floorboard</a>. His credit was trashed, and he once had to cut up his credit cards. He's said in interviews that he <a href="https://www.benzinga.com/personal-finance/25/02/43885487/billionaire-mark-cuban-said-the-first-step-to-getting-rich-is-giving-things-up-drink-water-eat-mac-and-cheese-and-save-every-penny">lived off macaroni and cheese</a> and powdered milk. That grit helped him spot the same in Mogentale.
He offered $500,000 for 20%. Mogentale countered at 15%. They settled at 17%.
"I just had professors who were like, ‘This deserves to exist in the world,'" she said of her early days, when a USC grant helped launch the brand after she pitched the idea in class. The inspiration? Watching a friend juice vegetables and throw out the pulp. Her first recipe? Carrot cookies.
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>
By the time of filming, Pulp Pantry had pulled in just under $250,000 in annual sales and sales and was expected to hit $500,000 by year's end. Production costs sat at $1.70 per bag, and retail prices ranged from $4.99 to $5.49. Despite the slow climb, Mogentale said the company was finally profitable — barely.
But Cuban saw potential. "These are companies on a mission to make the world a better place," he said, referencing his other snack-related investments like Unreal Deli and Wanna Date.
Post-Shark Tank, Pulp Pantry began expanding its distribution footprint — appearing in stores like Good Eggs, Ozark Natural Foods, Fresh Thyme, H-E-B's Central Market, GoPuff/BevMo, Imperfect Foods, and Vitacost.
Today, the brand rebranded as Trashy in early 2024 but stayed true to its mission. According to <a href="https://sharktankinsights.com/pulp-pantry-shark-tank-update/">Shark Tank Insights</a>, the company is now worth roughly $4.8 million, growing about 10% annually.&nbsp;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – Many are rushing to <a href="https://www.benzinga.com/money/mode-mobile-2">grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

Mark Cuban Invested $500,000 In A Potato-Free Chip Startup After The Founder Said Her Bank Account Dropped To $1,000 — 'We've All Been Negative'

An analyst downgraded AI cloud-computing company CoreWeave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) on Monday based on valuation concerns after its shares soared following <a href="https://www.benzinga.com/news/ipos/25/03/44520808/nvidia-backed-coreweave-ipo-5-things-investors-need-to-know-before-buying-shares">its March IPO.</a>
The CoreWeave Analyst: Bank of America analyst Brad Sills downgraded CoreWeave from Buy to Neutral and raised the price target from $76 to $185.
Read Also: <a href="https://www.benzinga.com/markets/ipos/25/06/45874849/will-rising-stars-circle-coreweave-perform-like-past-ipo-winners-reddit-astera-labs">Will Rising Stars Circle, CoreWeave Perform Like Past IPO Winners Reddit, Astera Labs?</a>
 The Analyst Takeaways: CoreWeave stock was downgraded due to overvaluation concerns, and Sills&#8217;s new investor note already prices the upside into shares.
The analyst said CoreWeave stock is up 145% since first-quarter financial results.
"We believe much of the near-term upside has been priced in and downgrade our rating to Neutral," Sills said.
The analyst said CoreWeave trades at a premium of 25x for its enterprise value divided by EBIT. Sills is also concerned the company will need "significant debt funding" to help with its capex buildout and revenue upside.
Sills sees CoreWeave&#8217;s competition with Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) as costly, as those companies have "much bigger scale" and can more easily spend on their capex.
While Sills highlighted the company&#8217;s high valuation and less upside with the recent share run-up, the analyst had several positive things to say about the stock, alongside the increasing price target.
The note highlights the stock&#8217;s positives, including new hyperscaler customers, expansion with OpenAI, and a recent debt raise at a lower rate.
"In Q1, CoreWeave signed a $4 billion expansion deal with OpenAI, only two months after the initial deal was announced in March, bringing the total contract value to $15.9 billion."
Sills aid AI capex growth rates are peaking, but still very healthy.
"Capital expenditures for AI infrastructure are forecasted to reach $206 billion in CY27, growing 4% y/y, down from 65% in CY25."
The analyst said new customer additions could help reduce customer concentration risk.
CRWV Price Action: CoreWeave stock is up 5.3% to $155.11 on Monday versus a trading range of $33.52 to $166.60 since going public. Shares are up 290% since the IPO.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45750724/exclusive-mays-20-most-searched-tickers-on-benzinga-pro-where-do-apple-palantir-coreweave-nvidia-rank">EXCLUSIVE: May&#8217;s 20 Most-Searched Tickers On Benzinga Pro — Where Do Apple, Palantir, CoreWeave, Nvidia Rank?</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Downgrades

Tech

AMZN

CRWV

GOOG

GOOGL

MSFT

CoreWeave's 290% Rally Raises Valuation Fears, Analyst Says 'Upside Has Been Priced In'

J.P. Morgan analyst Seth M. Seifman expects small- and mid-cap defense firms, including Kratos Defense &amp; Security Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>), Leonardo DRS Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRS#NASDAQ">DRS</a>), and Mercury Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>), to show stronger performance in the second half of 2025.
Seifman&#8217;s outlook is supported by easing concerns over budget uncertainty, supply chain disruptions, and program delays. He also cited increased efforts by the Department of Defense to expand the defense industrial base and accelerate next-generation technology initiatives. 
These developments are likely to benefit firms such as Kratos, with strong growth potential, and DRS, with robust cash flow and balance sheet strength.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/06/45751013/kratos-ge-aerospace-expand-small-engine-portfolio-with-new-propulsion-systems" target="_blank" rel="noreferrer noopener">Kratos, GE Aerospace Expand Small Engine Portfolio With New Propulsion Systems</a>
<h3 class="wp-block-heading">Kratos Defense: Growth Acceleration Expected in H2</h3>
Seifman raised Kratos&#8217;s December 2025 price target to <a target="_blank" href="https://www.benzinga.com/quote/KTOS/analyst-ratings" rel="noreferrer noopener">$44 from $33</a>, maintaining a Neutral rating. The new valuation is based on 40 times the firm&#8217;s estimated fiscal 2027 adjusted EBITDA of $180 million, discounted back one year.
He noted short-term challenges in Kratos&#8217; Unmanned segment and the transition of a microwave production facility, which are expected to weigh on second-quarter results. However, he projects significant growth acceleration in the second half of 2025 as major programs ramp up.
The analyst highlighted progress in Kratos&#8217; Tactical Drone initiatives, including apparent support from Marine Corps leadership. While the company is making strides in hypersonics—especially through MACH-TB 2.0—and may secure contracts under programs like Anaconda, Helios, and Vulcan, Seifman believes much of this potential is already reflected in the current share price.
<h3 class="wp-block-heading">Leonardo DRS: Poised to Outperform Peers</h3>
For Leonardo DRS, Seifman raised the December 2025 price target to <a target="_blank" href="https://www.benzinga.com/quote/DRS/analyst-ratings" rel="noreferrer noopener">$48 from $33</a>, maintaining a Neutral rating. The updated target is based on 40 times the 2026 adjusted EPS estimate of $1.21.
While the EPS estimate remains unchanged, strong first-quarter results suggest DRS could exceed its 2025 revenue guidance. Seifman sees margin improvement and believes the company deserves a valuation premium over larger peers due to its stronger growth profile.
He also views DRS as well-positioned to benefit from the U.S. government&#8217;s increased focus on shipbuilding, including potential opportunities in submarine systems. Its healthy balance sheet, he added, gives the company strategic flexibility for mergers, acquisitions, and potential capital returns.
<h3 class="wp-block-heading">Mercury Systems: Recovery Taking Shape</h3>
Seifman raised his December 2025 price target on Mercury Systems to <a target="_blank" href="https://www.benzinga.com/quote/MRCY/analyst-ratings" rel="noreferrer noopener">$56 from $48</a> while maintaining a Neutral rating. The valuation is based on 20 times the estimated 2026 EBITDA of approximately $180 million.
The analyst noted lingering concerns about Mercury&#8217;s execution and the long-term impact of prior missteps. However, fiscal 2025 could mark a turning point.
Seifman expects a book-to-bill ratio of 1.1 for the year, supported by $33 million in new orders.
Margin expansion remains a key focus. In line with company guidance, Seifman forecasts a 14% adjusted EBITDA margin in the fourth quarter and 11.8% for the full year. He expects margins to improve to 16% in 2026 and approach 20% over the longer term.
Price Action: KTOS trading higher by 2.06% at $42.09, DRS lower by 0.33% at $45.17, and MRCY down by 0.04% at $51.55 at the last check Monday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45954235/jpmorgan-calls-for-calm-amid-crude-spike-flags-3-energy-stocks-with-upto-35-upside" target="_blank" rel="noreferrer noopener">JPMorgan Calls For Calm Amid Crude Spike, Flags 3 Energy Stocks With Upto 35% Upside</a></li>
</ul>
Image: Shutterstock

KTOS

MRCY

Kratos Set For Lift-Off Despite Early Turbulence: JPMorgan Spotlights Mid-Cap Defense Firms

RBNE

Robin Energy shares are trading lower after the company announced a $5.1 million at-the-market registered direct offering of 965,000 shares at $5.25 per share.

Regencell Bioscience shares are trading higher. The company effected a 38-for-1 forward stock split.

Susquehanna analyst Shyam Patil initiates coverage on MNTN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNTN#NYSE">MNTN</a>) with a Positive rating and announces Price Target of $38.

Susquehanna Initiates Coverage On MNTN with Positive Rating, Announces Price Target of $38

Hudson Pacific Properties shares are trading higher after the company announced a $300 million investment from Cohen & Steers to support the company's balance sheet recapitalization.

Oppenheimer analyst Jason Helfstein maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Outperform and raises the price target from $665 to $775.

Oppenheimer Maintains Outperform on Meta Platforms, Raises Price Target to $775

MarineMax shares are trading higher after Citigroup maintained a Buy rating on the stock and raised its price target from $29 to $32.

ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) has outperformed the market over the past 5 years by 8.14% on an annualized basis producing an average annual return of 22.48%. Currently, ON Semiconductor has a market capitalization of $22.33 billion. 
Buying $1000 In ON: If an investor had bought $1000 of ON stock 5 years ago, it would be worth $2,723.50 today based on a price of $53.44 for ON at the time of writing.
<h3>ON Semiconductor's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750091413_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In ON Semiconductor 5 Years Ago Would Be Worth This Much Today

<a href="https://wwd.com/beauty-industry-news/beauty-features/coty-looks-to-be-for-sale-industry-sources-say-1237919041/" title="https://wwd.com/beauty-industry-news/beauty-features/coty-looks-to-be-for-sale-industry-sources-say-1237919041/">https://wwd.com/beauty-industry-news/beauty-features/coty-looks-to-be-for-sale-industry-sources-say-1237919041/</a>

Comments

Quince Therapeutics

Quince Therapeutics (QNCX) Opciones

Quince Therapeutics (NASDAQ:QNCX) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL